top of page
HOME
PORTFOLIO
TEAM
CONTACT
More
Use tab to navigate through the menu items.
Portfolio
Acquired by Kala Pharmaceuticals
NASDAQ: KALA
2021
Acquired by Novartis 2022
Acquired by Ligand 2020
bottom of page
